Free Trial

ExodusPoint Capital Management LP Sells 2,033 Shares of Markel Group Inc. (NYSE:MKL)

Markel Group logo with Multi-Sector Conglomerates background

ExodusPoint Capital Management LP reduced its stake in Markel Group Inc. (NYSE:MKL - Free Report) by 84.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 366 shares of the insurance provider's stock after selling 2,033 shares during the period. ExodusPoint Capital Management LP's holdings in Markel Group were worth $632,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Arete Wealth Advisors LLC grew its stake in shares of Markel Group by 8.3% during the fourth quarter. Arete Wealth Advisors LLC now owns 564 shares of the insurance provider's stock worth $974,000 after buying an additional 43 shares during the last quarter. Motley Fool Asset Management LLC grew its position in Markel Group by 6.8% during the 4th quarter. Motley Fool Asset Management LLC now owns 189 shares of the insurance provider's stock worth $326,000 after acquiring an additional 12 shares during the last quarter. OLD Mission Capital LLC bought a new stake in Markel Group during the 4th quarter worth $3,316,000. National Bank of Canada FI increased its holdings in Markel Group by 11.4% in the 4th quarter. National Bank of Canada FI now owns 2,707 shares of the insurance provider's stock worth $4,673,000 after purchasing an additional 278 shares in the last quarter. Finally, Roundview Capital LLC raised its position in Markel Group by 0.5% in the fourth quarter. Roundview Capital LLC now owns 4,347 shares of the insurance provider's stock valued at $7,504,000 after purchasing an additional 20 shares during the last quarter. 77.12% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently issued reports on MKL. StockNews.com downgraded Markel Group from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Royal Bank of Canada upped their price target on shares of Markel Group from $1,750.00 to $2,025.00 and gave the company a "sector perform" rating in a research report on Friday, February 7th. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $1,702.20.

Get Our Latest Stock Analysis on Markel Group

Markel Group Trading Up 0.6 %

Markel Group stock traded up $10.72 during mid-day trading on Thursday, hitting $1,773.97. 13,924 shares of the stock were exchanged, compared to its average volume of 47,964. The firm's fifty day simple moving average is $1,843.69 and its two-hundred day simple moving average is $1,748.60. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 0.26. Markel Group Inc. has a 12 month low of $1,417.65 and a 12 month high of $2,063.68. The stock has a market capitalization of $22.55 billion, a price-to-earnings ratio of 8.91 and a beta of 0.70.

Markel Group (NYSE:MKL - Get Free Report) last released its earnings results on Wednesday, February 5th. The insurance provider reported $20.51 earnings per share (EPS) for the quarter, missing the consensus estimate of $20.66 by ($0.15). Markel Group had a net margin of 16.34% and a return on equity of 7.55%. Analysts forecast that Markel Group Inc. will post 96.25 EPS for the current year.

Insider Buying and Selling

In related news, CEO Thomas Sinnickson Gayner purchased 100 shares of Markel Group stock in a transaction on Friday, February 7th. The stock was acquired at an average cost of $2,008.01 per share, for a total transaction of $200,801.00. Following the completion of the acquisition, the chief executive officer now owns 48,945 shares of the company's stock, valued at $98,282,049.45. This trade represents a 0.20 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Steven A. Markel sold 88 shares of the company's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $1,860.03, for a total transaction of $163,682.64. Following the transaction, the director now owns 63,436 shares in the company, valued at $117,992,863.08. This represents a 0.14 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 2,034 shares of company stock valued at $3,778,952 over the last 90 days. Company insiders own 1.66% of the company's stock.

Markel Group Company Profile

(Free Report)

Markel Group Inc, a diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany. The company offers general and professional liability, personal lines, marine and energy, specialty programs, and workers' compensation insurance products; and property coverages that include fire, allied lines, and other specialized property coverages, including catastrophe-exposed property risks, such as earthquake and wind.

Read More

Institutional Ownership by Quarter for Markel Group (NYSE:MKL)

Should You Invest $1,000 in Markel Group Right Now?

Before you consider Markel Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Markel Group wasn't on the list.

While Markel Group currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines